These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7843737)

  • 1. p53 mutations in nonmalignant human liver: fingerprints of aflatoxins?
    Ozturk M
    Hepatology; 1995 Feb; 21(2):600-1. PubMed ID: 7843737
    [No Abstract]   [Full Text] [Related]  

  • 2. p53 proteins and aflatoxin b1: the good, the bad, and the ugly.
    Liang TJ
    Hepatology; 1995 Oct; 22(4 Pt 1):1330-2. PubMed ID: 7557889
    [No Abstract]   [Full Text] [Related]  

  • 3. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
    Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
    Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geographic variation of p53 mutational profile in nonmalignant human liver.
    Aguilar F; Harris CC; Sun T; Hollstein M; Cerutti P
    Science; 1994 May; 264(5163):1317-9. PubMed ID: 8191284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma p53 G > T transversions at codon 249: the fingerprint of aflatoxin exposure?
    Lasky T; Magder L
    Environ Health Perspect; 1997 Apr; 105(4):392-7. PubMed ID: 9189703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure.
    Besaratinia A; Kim SI; Hainaut P; Pfeifer GP
    Gastroenterology; 2009 Sep; 137(3):1127-37, 1137.e1-5. PubMed ID: 19524575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 codon 249ser mutations in hepatocellular carcinoma patients with low aflatoxin exposure.
    Patel P; Stephenson J; Scheuer PJ; Francis GE
    Lancet; 1992 Apr; 339(8797):881. PubMed ID: 1347900
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidemiology of human aflatoxin exposures and their relationship to liver cancer.
    Groopman JD; Scholl P; Wang JS
    Prog Clin Biol Res; 1996; 395():211-22. PubMed ID: 8895991
    [No Abstract]   [Full Text] [Related]  

  • 9. Aflatoxin B1-induced rat hepatic hyperplastic nodules do not exhibit a site-specific mutation within the p53 gene.
    Hulla JE; Chen ZY; Eaton DL
    Cancer Res; 1993 Jan; 53(1):9-11. PubMed ID: 8380129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AFB1 hepatocarcinogenesis is via lipid peroxidation that inhibits DNA repair, sensitizes mutation susceptibility and induces aldehyde-DNA adducts at p53 mutational hotspot codon 249.
    Weng MW; Lee HW; Choi B; Wang HT; Hu Y; Mehta M; Desai D; Amin S; Zheng Y; Tang MS
    Oncotarget; 2017 Mar; 8(11):18213-18226. PubMed ID: 28212554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.
    Hsia CC; Kleiner DE; Axiotis CA; Di Bisceglie A; Nomura AM; Stemmermann GN; Tabor E
    J Natl Cancer Inst; 1992 Nov; 84(21):1638-41. PubMed ID: 1279184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1.
    Park US; Su JJ; Ban KC; Qin L; Lee EH; Lee YI
    Gene; 2000 Jun; 251(1):73-80. PubMed ID: 10863098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 mutation in hepatocellular carcinoma after aflatoxin exposure.
    Ozturk M
    Lancet; 1991 Nov; 338(8779):1356-9. PubMed ID: 1682737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aflatoxin and p53 abnormality in duck hepatocellular carcinoma.
    Imazeki F; Yokosuka O; Ohto M; Omata M
    J Gastroenterol Hepatol; 1995; 10(6):646-9. PubMed ID: 8580407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aflatoxin genotoxicity is associated with a defective DNA damage response bypassing p53 activation.
    Gursoy-Yuzugullu O; Yuzugullu H; Yilmaz M; Ozturk M
    Liver Int; 2011 Apr; 31(4):561-71. PubMed ID: 21382167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aflatoxin and hepatocellular carcinoma: a useful paradigm for environmentally induced carcinogenesis.
    Kolars JC
    Hepatology; 1992 Sep; 16(3):848-51. PubMed ID: 1324219
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma.
    Yakicier MC; Legoix P; Vaury C; Gressin L; Tubacher E; Capron F; Bayer J; Degott C; Balabaud C; Zucman-Rossi J
    Oncogene; 2001 Aug; 20(37):5232-8. PubMed ID: 11526514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations associated with in vivo aflatoxin B1-induced carcinogenesis need not be present in the in vitro transformations by this toxin.
    Stanley LA; Mandel HG; Riley J; Sinha S; Higginson FM; Judah DJ; Neal GE
    Cancer Lett; 1999 Apr; 137(2):173-81. PubMed ID: 10374839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis.
    Smela ME; Currier SS; Bailey EA; Essigmann JM
    Carcinogenesis; 2001 Apr; 22(4):535-45. PubMed ID: 11285186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
    Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.